Objective: To compare the efficacy of the second-generation antihistamine cetirizine with Nigella sativa (N. sativa) seeds in management of seasonal allergic rhinitis (SAR). Design: Comparative uncontrolled clinical trial. Subjects and Methods: Forty untreated adult patients, suffering from seasonal allergic rhinitis, seeking outpatient treatment were selected from different primary care clinics. They were enrolled and randomized in a single-blind manner to receive Cetirizine, 10 mg/day, group I (n=20) and 250 mg/day of N.sativa, group II (n=20) orally for 14 days. Response to treatment was evaluated at the end of the study. Results: All patients completed the treatment. Both study drugs i.e cetirizine and N.sativa were equally effective at relieving the symptoms of seasonal allergic rhinitis; however, the group using cetirizine had more sedation and other adverse effects. Conclusion: It appears that N.sativa is has minimal adverse effects and is therefore a safe treatment option for the patients of seasonal allergic rhinitis.